Sensei Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeSensei Bio
Sensei Bio logo

Sensei Bio

0 followers

SNSE

Performance

About Sensei Bio

Sensei Bio is a biotechnology company focused on developing cancer immunotherapies. The company pursues approaches inspired by the immune system to create treatments that empower the body to fight cancer. Its work spans research and development in oncology with a focus on therapies aimed at enabling the immune system to recognize and attack cancer cells. The organization communicates its mission through its global website and investor materials, indicating a U.S.-based biotechnology focus on advancing immuno-oncology.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Christopher Gerry

President & General Counsel

Anand Parikh

Chief Operating Officer

Josiah Craver

SVP, Finance

Key Facts

HQ Location

Rockville, United States

Founded

1999

Employees

11 - 50

Status

Public

Website

https://senseibio.com